Clinical Trials on Glabellar Crease in New Zealand

Total 2404 results

Keith D. Paulsen
Dartmouth College

Recruiting

MRg-NIRS Imaging System Breast Cancer Trial (MRg-NIRS)

Breast Cancer

United States
New Mexico Cancer Care Alliance

Completed

Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer

Breast Cancer

United States
Yale University

Completed

A Randomized Controlled Trial of Routine Shave Margins Versus Standard Partial Mastectomy in Breast Cancer Patients

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center

Completed

Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts

Breast Cancer

United States
Yale University

Completed

4D Image-Guided Partial Breast Radiation in Stage 0 and l Breast Cancer

Breast Cancer

United States
Yale University

Withdrawn

A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I Symporter

Breast Cancer

United States
Sanofi

Completed

Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center

Completed

Preserving Function in Breast Cancer Patients

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity

Breast Cancer | HER2-positive Breast Cancer | Cardiotoxicity | Breast Cancer Stage IV | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | HER2-positive Metastatic Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Recruiting

Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer

Early Stage Breast Cancer

United States
Novartis Pharmaceuticals

Completed

A Study of Real-World Outcomes of Ribociclib in First-Line Treatment for Metastatic HR+/HER2- Breast Cancer

Metastatic HR+/HER2- Breast Cancer

United States
Weill Medical College of Cornell University

Active, not recruiting

Accelerated Radiation Therapy (ART) to the Breast and Nodal Stations (ART)

Breast Cancer

United States
Pfizer

Completed

TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

Breast Cancer

United States
Weill Medical College of Cornell University

Active, not recruiting

Trial to Compare MRI-guided Precision Prone Irradiation (PPI) Versus CT-guided Breast Irradiation (PPI)

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Use of an Interactive 3D Tool During Consultation for Breast Reconstruction Surgery

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity

Breast Cancer

United States
Columbia University
National Institute on Minority Health and Health Disparities (NIMHD)

Suspended

Adherence Intervention in Patients With Metastatic Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Duke University

Completed

Trial Comparing the Effects of Linear Versus Nonlinear Aerobic Training in Women With Operable Breast Cancer (Excite)

Breast Cancer

United States
Columbia University
National Cancer Institute (NCI)

Completed

Cook for Your Life!: Implementing Dietary Change Among Hispanic Breast Cancer Survivors

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Genentech, Inc.; Amgen

Completed

Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Pharmacia

Completed

Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease

Breast Cancer

United States
Columbia University
National Cancer Institute (NCI)

Completed

Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting

Breast Neoplasm

United States
Memorial Sloan Kettering Cancer Center
Debiopharm International SA

Completed

A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer

Breast Cancer

United States
NYU Langone Health

Completed

Initial Assessment of 18FDG-PET/MRIin Determining the Extent of Systemic Disease in Breast Cancer Patients

Breast Cancer

United States
NYU Langone Health

Completed

Presurgical Trial of Denosumab in Breast Cancer

Breast Cancer

United States
Columbia University

Completed

CBPR - BRCA Genetic Testing Among Orthodox Jews

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer

Breast Cancer

United States
Columbia University
Avon Foundation

Completed

Vitamin D in Postmenopausal Women at High Risk for Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
GE Healthcare

Completed

FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients

Breast Cancer

United States
Icahn School of Medicine at Mount Sinai

Completed

A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Peptide Profiles of Women Undergoing Breast Biopsy

Breast Cancer

United States
Herbert Irving Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer

Breast Cancer

United States
Weill Medical College of Cornell University

Completed

Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer Surgery

Breast Cancer

United States
Prescient Therapeutics, Ltd.
National Cancer Institute (NCI)

Terminated

PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Breast Adenocarcinoma

United States
Roswell Park Cancer Institute

Completed

Exercise in Improving Health and Quality of Life in Breast Cancer Survivors

Invasive Breast Carcinoma

United States
Novartis Pharmaceuticals

Completed

Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors

Advanced Solid Tumors, Excluding Breast Cancer

United States
Roswell Park Cancer Institute

Completed

A Home-Based Walking Program and rTMS in Helping Breast Cancer Survivors Get More Physical Activity

Cancer Survivor | Invasive Breast Carcinoma

United States
Memorial Sloan Kettering Cancer Center
Queens Health Network; CHARLES B WANG COMMUNITY HEALTH CENTER; Cancer Support...

Withdrawn

Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer

Chinese Immigrants With Breast Cancer

United States
Monash University
Royal Perth Hospital

Recruiting

Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial (LOLIPOP)

Breast Cancer | Mastectomy | Breast Cancer Female | Breast Conserving Surgery

Australia, United Kingdom, Hong Kong, New Zealand
Novartis

Completed

Real-life Treatment Patterns With Cyclin-dependent Kinase Inhibitors in Advanced Breast Cancer in Portugal - REVEAL Study

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone-receptor-positive Breast Cancer

United States
Yale University
Novartis; Genentech, Inc.

Terminated

Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer

Breast Cancer | Hormone-Sensitive Breast Cancer

United States
Yale University
Astellas Pharma US, Inc.

Recruiting

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

United States
Montefiore Medical Center
Albert Einstein College of Medicine; Deciphera Pharmaceuticals LLC

Terminated

Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer

Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Breast Adenocarcinoma

United States
Columbia University

Completed

Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer

Breast Cancer

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer

Breast Cancer

United States
Agendia

Completed

The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients

Chinese

United States
Memorial Sloan Kettering Cancer Center
Monash University

Completed

The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer

Breast Cancer | Counseling

United States
SynCore Biotechnology Co., Ltd.

Suspended

A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer

Triple-Negative Breast Cancer

Taiwan

Clinical Trials on Glabellar Crease in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations